A further consideration on long-acting injectable versus oral antipsychotics in the treatment of schizophrenia: a narrative review and critical appraisal-Reference-Cited by-同舟云学术

A further consideration on long-acting injectable versus oral antipsychotics in the treatment of schizophrenia: a narrative review and critical appraisal

Published:2015-12-04 Issue:2 Volume:13 Page:253-264
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Suzuki Takefumi

Publisher

Informa Healthcare

Subject

Pharmaceutical Science

Link

http://www.tandfonline.com/doi/pdf/10.1517/17425247.2016.1115479

Reference90 articles.

1. Papers of special note have been highlighted as either of interest (•) or of considerable interest (••) to readers.

2. A review on schizophrenia and relapse-a quest for user-friendly psychopharmacotherapy

3. The nature of relapse in schizophrenia

4. Guidelines for depot antipsychotic treatment in schizophrenia

5. Treatment compliance in veterans administration schizophrenia spectrum patients treated with risperidone long-acting injectable

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Injectable long-acting formulations (ILAFs) and manufacturing techniques;Expert Opinion on Drug Delivery;2024-06-02

2. Weight changes in people with early psychosis treated with oral or long-acting injectable aripiprazole;Schizophrenia Research;2023-01

3. Psychiatric healthcare resource utilization following initiation of aripiprazole once-monthly: a retrospective real-world study;Current Medical Research and Opinion;2022-12-17

4. Risperidone ISM as a New Option in the Clinical Management of Schizophrenia: A Narrative Review;Advances in Therapy;2022-09-01

5. Digital pills for the remote monitoring of medication intake: a stakeholder analysis and assessment of marketing approval and patent granting policies;J LAW BIOSCI;2022